Does This Move Make Merck Stock a Buy?

Key PointsMerck is seeking ways to prepare for a significant upcoming patent cliff.The company has just announced another acquisition that will help it achieve that goal.With its newer products, strong dividend, and reasonable valuation, Merck still looks attractive. 10 stocks we like better than Merck › Merck (NYSE: MRK), a leading pharmaceutical company, generates consistent revenue and profits. However, the stock has been under pressure over the past year due to its reliance on Keytruda, its ...